{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:57:55Z","timestamp":1781287075453,"version":"3.54.1"},"reference-count":37,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2026,6,2]]},"DOI":"10.1136\/ejhpharm-2025-004917","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:20:15Z","timestamp":1781284815000},"page":"ejhpharm-2025-004917","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["On-label paediatric drug product information in Switzerland \u2013 the neglected child"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9093-4178","authenticated-orcid":false,"given":"Lukas","family":"Higi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland"},{"name":"PEDeus AG, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Palmero","sequence":"additional","affiliation":[{"name":"Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland"},{"name":"Paediatrics Working Group, Swiss Association Public Health Administration and Hospital Pharmacists (GSASA), Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rudolf von Rohr","sequence":"additional","affiliation":[{"name":"Paediatrics Working Group, Swiss Association Public Health Administration and Hospital Pharmacists (GSASA), Bern, Switzerland"},{"name":"Pharmacy, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Timmermann","sequence":"additional","affiliation":[{"name":"Paediatrics Working Group, Swiss Association Public Health Administration and Hospital Pharmacists (GSASA), Bern, Switzerland"},{"name":"Hospital Pharmacy, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Roussel","sequence":"additional","affiliation":[{"name":"Paediatrics Working Group, Swiss Association Public Health Administration and Hospital Pharmacists (GSASA), Bern, Switzerland"},{"name":"Pharmacy of the Eastern Vaud Hospitals, Rennaz, VD, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Gotta","sequence":"additional","affiliation":[{"name":"Pediatric Pharmacology and Pharmacometrics, University Children\u2019s Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-2601","authenticated-orcid":false,"given":"Priska","family":"Vonbach","sequence":"additional","affiliation":[{"name":"PEDeus AG, Z\u00fcrich, ZH, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"K\u00e4ser","sequence":"additional","affiliation":[{"name":"PEDeus AG, Z\u00fcrich, Switzerland"},{"name":"Paediatrics Working Group, Swiss Association Public Health Administration and Hospital Pharmacists (GSASA), Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2026061210201170000_ejhpharm-2025-004917v1.1","unstructured":"Refdata Foundation . SwissMedicInfo. Available: https:\/\/www.swissmedicinfo.ch\/?Lang=EN [Accessed 23 Oct 2025]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.2","unstructured":"Bundesgesetz \u00fcber Arzneimittel und Medizinprodukte (Heilmittelgesetz, HMG) [Therapeutic Products Act, TPA], SR 812.21,"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.3","unstructured":"Verordnung des Schweizerischen Heilmittelinstituts \u00fcber die Anforderungen an die Zulassung von Arzneimitteln (Arzneimittel-Zulassungsverordnung, AMZV) [Therapeutic Products Licensing Requirements Ordinance, TPLRO], SR 812.212.22,"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.4","unstructured":"Verordnung \u00dcber Die Arzneimittel (Arzneimittelverordnung, VAM) [Therapeutic Products Ordinance, TPO], SR 812.212.21,"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.5","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645110-00003"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00431-019-03556-9","article-title":"Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology","volume":"179","author":"Schrier","year":"2020","journal-title":"Eur J Pediatr"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.7","unstructured":"Swissmedic . Medicines for children. 2014. Available: https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/humanarzneimittel\/besondere-arzneimittelgruppen--ham-\/paediatrie.html [Accessed 23 Oct 2025]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40290-024-00519-w","article-title":"Authorized or Off-Label Use? A Structured Analysis of Summaries of Product Characteristics with Regard to Authorization in Pediatrics","volume":"38","author":"Herzig","year":"2024","journal-title":"Pharm Med"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.9","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2023-325611"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.10","unstructured":"Swissmedic . Guidance document - product information for human medicinal products, v5.0, zl000_00_027. Available: https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/services\/documents\/humanarzneimittel_hmv4.html [Accessed 4 Oct 2024]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.11","unstructured":"International council for harmonisation of technical requirements for pharmaceuticals for human use. addendum to ICH E11: clinical investigation of medicinal products in the pediatric population E11 (R1). 2017. Available: https:\/\/www.ich.org\/page\/efficacy-guidelines [Accessed 18 Jul 2018]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.12","doi-asserted-by":"crossref","unstructured":"van den Anker J , Reed MD , Allegaert K , et al . Developmental Changes in Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharma 2018;58. doi:10.1002\/jcph.1284","DOI":"10.1002\/jcph.1284"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2006.tb02378.x"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.14","article-title":"Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis","volume":"9","author":"Bhatt","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.15","unstructured":"Kinderformularium. Available: https:\/\/kinderformularium.nl [Accessed 23 Oct 2025]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.16","unstructured":"INFECTOPHARM arzneimittel, und consilium GmbH, INFECTOPHARM. GERNEBCIN 40 mg\/1 ml, GERNEBCIN 80 mg\/2 ml [SmPC]. Available: https:\/\/fachinfo.de\/fi\/detail\/012932\/gernebcin-40-mg-1-ml-gernebcin-80-mg-2-ml [Accessed 23 Oct 2025]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.17","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2016-001117"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-020-02384-3","article-title":"A modified Delphi to define drug dosing errors in pediatric critical care","volume":"20","author":"Roumeliotis","year":"2020","journal-title":"BMC Pediatr"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.4.737"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00228-012-1440-1","article-title":"Categorising paediatric prescribing errors by junior doctors through prescribing competency assessment: does assessment reflect actual practice?","volume":"69","author":"Davis","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/pan.13574","article-title":"Society for the advancement of blood management administrative and clinical standards for patient blood management programs. 4th edition (pediatric version)","volume":"29","author":"Goobie","year":"2019","journal-title":"Paediatr Anaesth"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11096-023-01652-3","article-title":"Implementation of a national system for best practice delivery of paediatric infusions","volume":"46","author":"Howlett","year":"2024","journal-title":"Int J Clin Pharm"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.23","unstructured":"Neonatal & Paediatric Pharmacy Group . Standardising intravenous infusion concentrations for neonates and children in the UK. 2024. Available: https:\/\/nppg.org.uk\/wp-content\/uploads\/2025\/01\/Standard-Infusions-Nov-2024-Final.pdf [Accessed 6 Mar 2026]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.24","article-title":"Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants","volume":"2014","author":"Bell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.25","unstructured":"Deutsche gesellschaft f\u00fcr an\u00e4sthesiologie und intensivmedizin e.v. s2k-leitlinie medikamentensicherheit in der kinderan\u00e4sthesie. AWMF; 2021. Available: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/001-033 [Accessed 23 Oct 2025]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.26","doi-asserted-by":"crossref","first-page":"151541","DOI":"10.1016\/j.semperi.2021.151541","article-title":"Fluid management considerations in extremely preterm infants born at 22-24 weeks of gestation","volume":"46","author":"\u00c5gren","year":"2022","journal-title":"Semin Perinatol"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.06.956"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.xphs.2016.09.034","article-title":"If Euhydric and Isotonic Do Not Work, What Are Acceptable pH and Osmolality for Parenteral Drug Dosage Forms?","volume":"106","author":"Roethlisberger","year":"2017","journal-title":"J Pharm Sci"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-017-9558-5"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.31","article-title":"Intravenous in-line filters for preventing morbidity and mortality in neonates","volume":"2015","author":"Foster","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/pde.12664","article-title":"Severe Extravasation Injuries in Neonates: A Report of 34 Cases","volume":"32","author":"Kostogloudis","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/1060028020903406","article-title":"Extravasation of Noncytotoxic Drugs","volume":"54","author":"David","year":"2020","journal-title":"Ann Pharmacother"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.34","unstructured":"Leitlinienprogramm-onkologie (deutsche krebsgesellschaft, deutsche krebshilfe, AWMF). s3-leitlinie supportive therapie bei onkologischen patientinnen. Available: https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/supportive-therapie\/ [Accessed 23 Oct 2025]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.35","first-page":"8","article-title":"Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review","volume":"12","author":"Borgonovo","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"2026061210201170000_ejhpharm-2025-004917v1.36","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA) . Wockhardt UK ltd - amoxicillin sodium 1g, 250mg and 500mg powder for solution for injection. 2015. Available: https:\/\/www.gov.uk\/drug-device-alerts\/amoxicillin-sodium-1g-250mg-and-500mg-powder-for-solution-for-injection-do-not-use-for-treating-neonates-and-infants-below-one-year-old#update-august-2020 [Accessed 11 Oct 2025]."},{"key":"2026061210201170000_ejhpharm-2025-004917v1.37","unstructured":"Regulation (EC) no 1901\/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending regulation (EEC) no 1768\/92, directive 2001\/20\/EC, directive 2001\/83\/EC and regulation (EC) no 726\/2004. vol 378. 2006. Available: http:\/\/data.europa.eu\/eli\/reg\/2006\/1901\/oj [Accessed 19 Mar 2026]."}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:20:24Z","timestamp":1781284824000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":37,"alternative-id":["10.1136\/ejhpharm-2025-004917"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004917","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}